...
首页> 外文期刊>Pediatrics: Official Publication of the American Academy of Pediatrics >REPLACEMENT TRANSFUSION AS A TREATMENT FOR ERYTHROBLASTOSIS FETALIS
【24h】

REPLACEMENT TRANSFUSION AS A TREATMENT FOR ERYTHROBLASTOSIS FETALIS

机译:置换输血治疗红细胞增生病。

获取原文
           

摘要

THE treatment of hemolytic anemia of the newborn often requires support by compatible blood transfusions. In the years before the discovery of the Rh factor, such blood was usually compatible only according to the A-B-O group, and for convenience the patient's father was often used as a donor. This meant the use of Rh-positive blood. It was found frequently at this time that the infants' blood levels tended to fall rapidly even with repeated transfusions. In many such cases the infused Rh-positive cells are destroyed much more rapidly than are Rh-negative cells as shown by Mollison in England and confirmed by us. It seemed best, therefore, as a first step in improving treatment, to use only Rh-negative blood as a means of achieving the highest blood levels for protection of the patient, and this step was logically inaugurated after 1941.In the more acute and severe cases of erythroblastosis the infant's anemia often progressed so rapidly in the first 48 hours that several small transfusions proved inadequate. In such patients, by recently developed technics, it has been possible to demonstrate that the serum of the baby still contains free maternal anti-Rh agglutinins and that all of the infant's own red blood cells are often completely coated with this antibody leading probably to a more rapid destruction of the infant's cells. The removal of as much as possible of the baby's own blood should theoretically help diminish the damage resulting from the presence of this free and bound antibody in the circulation and in the tissues. Such reasoning led to the trial of replacement transfusion for the treatment of erythroblastosis. Replacement transfusion is not a new procedure in pediatric practice as many of you know, but to perform it in a newborn infant has added difficulty to an inherently difficult technic.The earlier method consisted of entering the longitudinal sinus and a peripheral vein, or two peripheral veins, or a vein and an artery. These usually required more or less body exposure for a newborn infant on an operating table, often requiring an hour or more for the procedure and this sometimes caused shock-like symptoms from cold and trauma.
机译:新生儿溶血性贫血的治疗通常需要相容性输血的支持。在发现Rh因子之前的几年中,这种血液通常仅按照A-B-O组的标准才是兼容的,为方便起见,经常将患者的父亲用作捐赠者。这意味着使用Rh阳性血液。在这个时候经常发现,即使反复输血,婴儿的血液水平也有迅速下降的趋势。在许多此类情况下,输注的Rh阳性细胞的破坏速度要比Rh阴性细胞破坏的速度快得多,正如英国的Mollison所显示并得到我们的证实。因此,作为改善治疗的第一步,似乎最好只使用Rh阴性血作为达到最高血液水平以保护患者的手段,并且从1941年开始逻辑上开始了这一步骤。严重的成血红细胞增多症病例,婴儿的贫血通常在开始的48小时内发展得如此之快,以至于几次输血不足。在这种患者中,通过最新开发的技术,有可能证明婴儿的血清中仍然含有游离的母体抗Rh凝集素,而且婴儿自身所有的红细胞通常都被该抗体完全包被,可能导致更迅速地破坏婴儿的细胞。从理论上说,尽可能多地除去婴儿自身的血液应有助于减少由于这种游离的结合抗体在循环系统和组织中的存在而造成的损害。这种推理导致了替代输血治疗成红细胞病的试验。众所周知,置换输血不是儿科实践中的新方法,但是在新生婴儿中进行置换增加了本来就很困难的技术的难度。较早的方法包括输入纵窦和外周静脉,或两条外周静脉。静脉,或静脉和动脉。对于刚出生的婴儿,这些通常需要在手术台上或多或少地暴露于身体,通常需要一个小时或更长的时间进行手术,有时会因感冒和创伤而引起类似休克的症状。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号